ब्रेन ट्यूमर (मेड्युलोब्लास्टोमा)
Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline
कुठे जायचं
या ट्रायलसाठी भारतातील १ हॉस्पिटल रुग्णांना घेत आहे.
रजिस्ट्री सारांश (तांत्रिक)
Radiation constitutes an integral component in the management of primary brain tumors in pediatric and young adults like medulloblastoma, ependymoma, low-grade glioma, pituitary tumors, etc. A decline in neurocognitive outcomes is a multifactorial effect occurring from the primary disease as well as associated with treatments, including radiation. Since many of these tumors are highly curable, it is crucial to reduce long-term side effects, including memory loss, to improve the quality of life in these patients, leading to better rehabilitation. Radiation-induced neurocognitive deterioration i…
Sponsor: Tata Memorial Centre
ClinicalTrials.gov वर NCT06779487
रजिस्ट्रीवर शेवटचे अपडेट 11 Apr 2025 · आम्ही वाचले 20 Oct 2026